156 related articles for article (PubMed ID: 36643088)
1. A Comprehensive Analysis of Topiramate and Drug Reaction With Eosinophilia and Systemic Symptoms.
Thoms A; Muller P; Schaufelberger B; De La Torre E; Smugar SS
Cureus; 2023 Jan; 15(1):e33713. PubMed ID: 36643088
[TBL] [Abstract][Full Text] [Related]
2. Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases.
de Filippis R; Kane JM; Kuzo N; Spina E; De Sarro G; de Leon J; De Fazio P; Schoretsanitis G
Eur Neuropsychopharmacol; 2022 Jul; 60():25-37. PubMed ID: 35635994
[TBL] [Abstract][Full Text] [Related]
3. Vemurafenib Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Disproportionality Analysis in FAERS Database.
Neha R; Beulah E; Anusha B; Vasista S; Stephy C; Subeesh V
Curr Rev Clin Exp Pharmacol; 2021; 16(2):168-173. PubMed ID: 32598268
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel signal of clobazam-associated drug reaction with eosinophilia and systemic symptoms syndrome: A disproportionality analysis.
Sharma A; Kumar A
Acta Neurol Scand; 2022 Nov; 146(5):623-627. PubMed ID: 36029138
[TBL] [Abstract][Full Text] [Related]
5. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017.
Kim HK; Kim DY; Bae EK; Kim DW
J Korean Med Sci; 2020 Feb; 35(4):e17. PubMed ID: 31997613
[TBL] [Abstract][Full Text] [Related]
6. Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by phenytoin re-exposure: case report and systematic review.
Morán-Mariños C; Alva-Diaz C; De la Cruz Ramirez W; Quincho-Lopez A; Mori N; Pacheco-Mendoza J; Romero-Sánchez R
Acta Clin Belg; 2022 Feb; 77(1):177-185. PubMed ID: 32469684
[No Abstract] [Full Text] [Related]
7. The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase.
Battini V; Van Manen RP; Gringeri M; Mosini G; Guarnieri G; Bombelli A; Pozzi M; Nobile M; Radice S; Clementi E; Carnovale C
Front Pharmacol; 2023; 14():1128387. PubMed ID: 36873988
[No Abstract] [Full Text] [Related]
8. No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database.
Napoli AA; Wood JJ; Coumbis JJ; Soitkar AM; Seekins DW; Tilson HH
J Int AIDS Soc; 2014; 17(1):19214. PubMed ID: 25192857
[TBL] [Abstract][Full Text] [Related]
9. Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review.
de Filippis R; Soldevila-Matías P; Guinart D; De Fazio P; Rubio JM; Kane JM; Schoretsanitis G
J Psychopharmacol; 2021 Sep; 35(9):1062-1073. PubMed ID: 34044659
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea.
Lee JY; Lee SY; Hahm JE; Ha JW; Kim CW; Kim SS
Int J Dermatol; 2017 Sep; 56(9):944-951. PubMed ID: 28718873
[TBL] [Abstract][Full Text] [Related]
11. RegiSCAR DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) Validation Scoring System and Japanese Consensus Group Criteria for Atypical Drug-Induced Hypersensitivity Syndrome (DiHS): A Comparative Analysis.
Sasidharanpillai S; Ajithkumar K; Jishna P; Khader A; Anagha KV; Binitha MP; Chathoth AT
Indian Dermatol Online J; 2022; 13(1):40-45. PubMed ID: 35198466
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular safety signals with dipeptidyl peptidase-4 inhibitors: A disproportionality analysis among high-risk patients.
Baksh SN; McAdams-DeMarco M; Segal JB; Alexander GC
Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):660-667. PubMed ID: 29655237
[TBL] [Abstract][Full Text] [Related]
13. Peripheral neuropathy and Guillain-Barré syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis.
Ali AK
Ann Epidemiol; 2014 Apr; 24(4):279-85. PubMed ID: 24472364
[TBL] [Abstract][Full Text] [Related]
14. A real-world pharmacovigilance study of severe cutaneous adverse reactions associated with antiepileptic drug combination therapy: data mining of FDA adverse event reporting system.
Wei C; Zhang J; Yin W; Jiang A; Liu Y; Wu B
Expert Opin Drug Saf; 2023; 22(6):509-515. PubMed ID: 36373417
[TBL] [Abstract][Full Text] [Related]
15. Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population.
Ramírez E; Bellón T; Tong HY; Borobia AM; de Abajo FJ; Lerma V; Moreno Hidalgo MA; Castañer JL; Cabañas R; Fiandor A; González-Ramos J; Herranz P; Cachafeiro L; González-Herrada C; González O; Aramburu JA; Laosa O; Hernández R; Carcas AJ; Frías J
Pharmacol Res; 2017 Jan; 115():168-178. PubMed ID: 27888155
[TBL] [Abstract][Full Text] [Related]
16. Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome Due to Vancomycin.
Kulkarni MP; Chinta S; Sosa F; Nasr R; Kelly P
Cureus; 2022 Jun; 14(6):e26219. PubMed ID: 35911307
[TBL] [Abstract][Full Text] [Related]
17. Ivermectin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Kerneuzet I; Blind E; Darrieux L; Moreau S; Safa G
JAAD Case Rep; 2018 Jul; 4(6):524-527. PubMed ID: 30023418
[No Abstract] [Full Text] [Related]
18. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature, with a focus on relapsing cases.
Afiouni R; Zeinaty P; Kechichian E; Zoghaib S; Matar S; Helou-Mallat J; Tomb R
Pediatr Dermatol; 2021 Jan; 38(1):125-131. PubMed ID: 33155729
[TBL] [Abstract][Full Text] [Related]
19. Severe cutaneous adverse reactions in Asians: Trends observed in culprit anti-seizure medicines using VigiBase®.
Shukla S; Rastogi S; Abdi SAH; Dhamija P; Kumar V; Kalaiselvan V; Medhi B
Seizure; 2021 Oct; 91():332-338. PubMed ID: 34274893
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review.
Taweesedt PT; Nordstrom CW; Stoeckel J; Dumic I
Biomed Res Int; 2019; 2019():7863815. PubMed ID: 31662996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
